Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Revolution in Roller Rack Apparatus Equipment for Adherent Cell Culture

Published: Friday, October 12, 2012
Last Updated: Friday, October 12, 2012
Bookmark and Share
The new WHEATON® R2P® 2.0 Roller System combines a new level of control with Ethernet networking capabilities in numerous bottle rolling configurations.

WHEATON has introduced a revolution in adherent cell culture equipment. The R2P 2.0 is the first touch screen, Ethernet network-capable roller culture device for the vaccine and biologics industry.

Designed for robustness and ease of use, units are fully configurable to meet demanding biopharmaceutical process requirements.

WHEATON roller apparatus are used worldwide for research and production of therapeutic antibodies, vaccines, proteins and cells.

The R2P 2.0 automatically controls and monitors the rotational speed of the cell culture bottles with a service-free, high precision motor.

A single apparatus can rotate up to 176 bottles. The settings on the R2P 2.0 are controlled through a color touch screen that displays all prominent process parameters and system alarms.

Parameters are accessed through readily recognizable icons and changed through intuitive configuration screens. The units are also compatible with existing networked WHEATON roller apparatus for plug and play backwards compatibility.

The WHEATON R2P 2.0 also has a USB downloadable internal event log file to record any parameter changes or alarm notifications.

Available options for the R2P 2.0 include temperature sensors and automatic battery backup to ensure an optimal environment for cell growth.

Custom configurations are available to accommodate scientists with specific requirements. International customers can specify country specific plug sets to assure electrical power supply is locally compatible.

WHEATON offers a variety of related equipment and consumables to support roller bottle cell culture.

“Careful cultivation of adherent cells in roller bottles demands a roller rack with the features we built-in to the R2P 2.0 Roller System,” said Stephen R. Drozdow, president of WHEATON.

“We strive to continually introduce advanced products with features scientists tell us they want, which is a never ending challenge as technology continues to evolve…but we’re up to it,” he added.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Cancer Discovery Links Experimental Vaccine and Biological Treatment
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!